*ST吉药
(300108)
| 流通市值：1.37亿 | | | 总市值：1.40亿 |
| 流通股本：6.53亿 | | | 总股本：6.66亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 30,902,041.99 | 15,756,568.83 | 24,509,161.98 | 20,261,611.35 |
| 应收票据及应收账款 | 124,730,435 | 124,372,362.79 | 107,658,284.39 | 120,850,122.8 |
| 其中：应收票据 | 6,935,528.25 | - | 969,684.26 | 821,165.2 |
| 应收账款 | 117,794,906.75 | 124,372,362.79 | 106,688,600.13 | 120,028,957.6 |
| 应收款项融资 | - | 14,580,052.21 | 23,790,145.31 | 24,118,682.99 |
| 预付款项 | 28,025,874.88 | 22,948,818.04 | 21,771,771.3 | 23,428,671.01 |
| 其他应收款合计 | 18,945,859.62 | 12,697,721.56 | 15,642,024.95 | 16,178,626.78 |
| 存货 | 58,879,012.01 | 62,041,365.92 | 61,228,529.71 | 58,048,573.84 |
| 其他流动资产 | 4,571,333.47 | 57,962,906.68 | 57,964,478.56 | 73,764,447.23 |
| 流动资产合计 | 266,054,556.97 | 310,359,796.03 | 312,564,396.2 | 336,650,736 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 45,492,260 | 10,000,000 | 10,000,000 | 76,762,411.96 |
| 固定资产 | 403,139,592.77 | 410,274,929.85 | 419,373,849.49 | 500,374,349.93 |
| 在建工程 | 330,903,154.98 | 330,706,359.31 | 330,736,359.31 | 398,020,404.44 |
| 使用权资产 | 849,481.49 | 849,481.49 | 1,225,882.49 | 374,412.3 |
| 无形资产 | 117,939,363.15 | 121,104,587.97 | 124,199,679.17 | 147,619,478.05 |
| 商誉 | 235,535,081.43 | 235,535,081.43 | 235,535,081.43 | 313,091,596.68 |
| 长期待摊费用 | 679,547.38 | 557,047.38 | 552,046.38 | 183,848.16 |
| 递延所得税资产 | 1,964,182.23 | 1,964,182.23 | 2,890,909.65 | 2,145,499.71 |
| 其他非流动资产 | 2,720,311.5 | 7,618,691.26 | 7,434,303.26 | 7,382,785.77 |
| 非流动资产合计 | 1,139,222,974.93 | 1,118,610,360.92 | 1,131,948,111.18 | 1,445,954,787 |
| 资产总计 | 1,405,277,531.9 | 1,428,970,156.95 | 1,444,512,507.38 | 1,782,605,523 |
| 流动负债: | | | | |
| 短期借款 | 612,095,991.1 | 612,096,046.41 | 612,096,046.41 | 667,096,046.41 |
| 应付票据及应付账款 | 176,902,746.32 | 184,464,414.03 | 179,423,345.16 | 184,249,684.02 |
| 应付账款 | 176,902,746.32 | 184,464,414.03 | 179,423,345.16 | 184,249,684.02 |
| 预收款项 | 27,849,604.04 | - | - | - |
| 合同负债 | 8,388,087.43 | 30,842,477.75 | 30,483,601.87 | 30,403,487.09 |
| 应付职工薪酬 | 38,944,484.23 | 37,448,746.99 | 42,446,343.73 | 41,852,862.38 |
| 应交税费 | 52,130,328.69 | 57,648,801.04 | 56,086,566.86 | 55,888,994.19 |
| 其他应付款合计 | 1,149,126,424.29 | 1,119,665,312.16 | 1,078,443,815.56 | 1,019,773,624.46 |
| 其中:应付利息 | 572,316,056.13 | 554,930,731.6 | 522,774,816.58 | 528,333,572.46 |
| 应付股利 | 10,173,718.53 | - | - | - |
| 一年内到期的非流动负债 | - | 44,257,784.98 | 44,257,784.98 | 44,190,625.51 |
| 其他流动负债 | 1,496,257 | 4,016,537.73 | 5,001,462.78 | 3,769,945.07 |
| 流动负债合计 | 2,066,933,923.1 | 2,090,440,121.09 | 2,048,238,967.35 | 2,047,225,269.13 |
| 非流动负债: | | | | |
| 长期借款 | 676,019,886.97 | 676,019,886.97 | 676,059,729.74 | 676,130,782.54 |
| 租赁负债 | 860,708.16 | 520,249.17 | 520,249.17 | 60,453.65 |
| 长期应付款 | 43,917,325.99 | - | - | - |
| 预计负债 | 225,697,086.7 | 225,168,684.08 | 218,113,499.39 | 154,707,789.27 |
| 递延收益 | 1,165,037.57 | 1,590,708.95 | 1,617,590.33 | 1,502,610.12 |
| 递延所得税负债 | 3,003,037.1 | 3,164,446.78 | 3,340,151.26 | 4,071,607.87 |
| 非流动负债合计 | 950,663,082.49 | 906,463,975.95 | 899,651,219.89 | 836,473,243.45 |
| 负债合计 | 3,017,597,005.59 | 2,996,904,097.04 | 2,947,890,187.24 | 2,883,698,512.58 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 666,014,674 | 666,014,674 | 666,014,674 | 666,014,674 |
| 资本公积 | 1,601,456,761.15 | 1,601,456,761.15 | 1,601,456,761.15 | 1,601,456,761.15 |
| 减:库存股 | 38,367,000 | 38,367,000 | 38,367,000 | 38,367,000 |
| 其他综合收益 | -78,273,700 | -78,273,700 | -78,273,700 | -21,860,088.04 |
| 盈余公积 | 88,230,286.24 | 88,230,286.24 | 88,230,286.24 | 88,230,286.24 |
| 未分配利润 | -3,097,297,583.4 | -3,060,755,075.42 | -3,015,580,472.75 | -2,807,383,448.6 |
| 归属于母公司股东权益合计 | -858,236,562.01 | -821,694,054.03 | -776,519,451.36 | -511,908,815.25 |
| 少数股东权益 | -754,082,911.68 | -746,239,886.06 | -726,858,228.5 | -589,184,174.33 |
| 股东权益合计 | -1,612,319,473.69 | -1,567,933,940.09 | -1,503,377,679.86 | -1,101,092,989.58 |
| 负债和股东权益合计 | 1,405,277,531.9 | 1,428,970,156.95 | 1,444,512,507.38 | 1,782,605,523 |
| 公告日期 | 2025-08-29 | 2025-04-29 | 2025-04-29 | 2024-10-30 |
| 审计意见(境内) | | | 无法表示意见 | |